BioSenic fait le point sur ses activités du premier trimestre 2024
May 24, 2024 11:00 ET
|
BioSenic
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 24 mai 2024 à 17h00 CEST – BIOSENIC (Euronext Bruxelles et Paris : BIOS), la société en phase clinique spécialisée...
BioSenic provides First Quarter 2024 Business Update
May 24, 2024 11:00 ET
|
BioSenic
PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, May 24, 2024, 17.00am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious...
Legacy Housing Corporation Reports First Quarter 2024 Financial Results
May 09, 2024 17:00 ET
|
Legacy Housing Corporation
Legacy Housing Corporation Reports First Quarter 2024 Financial Results
Innospec Reports First Quarter 2024 Financial Results
May 09, 2024 16:45 ET
|
Innospec Inc.
Strong contribution from Performance Chemicals drives operating income growth of 23 percent $80.6 million cash generated from operations; Net cash improves to $270.1 million Dividend...
AvePoint Announces First Quarter 2024 Financial Results
May 09, 2024 16:05 ET
|
AvePoint, Inc.
First quarter SaaS revenue of $51.3 million, representing 44% year-over-year growthFirst quarter Total revenue of $74.5 million, representing 25% year-over-year growthTotal ARR of $274.5 million,...
SmartCentres Real Estate Investment Trust Releases First Quarter Results for 2024
May 08, 2024 17:35 ET
|
SmartCentres Real Estate Investment Trust
SMARTCENTRES REAL ESTATE INVESTMENT TRUST RELEASES FIRST QUARTER RESULTS FOR 2024
Sezzle Reports First-Quarter 2024 Results
May 08, 2024 16:21 ET
|
Sezzle
Minneapolis, MN, May 08, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, is pleased to update the market on key financial...
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
May 08, 2024 07:30 ET
|
InflaRx N.V.
Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the opportunity, the role of C5aR in chronic spontaneous urticaria (CSU) and...
Stella-Jones annonce ses résultats du premier trimestre
May 08, 2024 07:00 ET
|
Stella-Jones Inc
Ventes de 775 millions $, en hausse de 9 %, portées par la croissance interne des catégories de produits d'infrastructures Hausse de 30 % du BAIIA qui atteint un niveau record au premier trimestre de...
Stella-Jones Announces First Quarter Results
May 08, 2024 07:00 ET
|
Stella-Jones Inc.
Sales of $775 million, up 9%, driven by organic sales growth in infrastructure product categoriesRecord first quarter EBITDA up 30% to $156 million, a margin of 20.1%Net income of $77 million or $1.36...